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Thallium-20l uptake and clearance after dipyridamole
infusion may differ from that after exercise stress be-
cause the hemodynamic effects of these two interventions
are different. In this study of normal volunteers, thal-
lium kinetics after dipyridamole (n = 13) were deter -
mined from three serial image sets (early, intermediate
and delayed) and from serial blood samples and com-
pared with thallium kinetics after exercise (n = 15).
Absolute myocardial thallium uptake was greater after
dipyridamole compared with exercise (p < 0.0001), al-
though the relative myocardial distribution was similar .
The myocardial clearance (%/h) of thallium was slower
after dipyridamole than it was after exercise. Comparing
dipyridamole and exercise, the differences in clearance
were large from the early to the intermediate image
(anterior , -11 ± 17 versus 24 ± 5, P = 0.0005; 50°
left anterior oblique, -7 ± II versus 15 ± 8, p =
0.004; 70° left anterior oblique, 3 ± 9 versus 21 ± 6,
Quantitative computer techniques for analyzing the myo-
cardial uptake and clearance of thallium-20I have increased
the diagnostic accuracy of exercise thallium by using di-
agnostic criteria based on thallium kinetics in normal sub-
jects (1,2). In patients unable to exercise. stress thallium
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p =0.001). In contrast, the differences in clearance were
small from the intermediate to the delayed image (an-
terior, 15 ± 4 versus 20 ± 2, p = 0.025; 50°left anterior
oblique, 15 ± 4 versus 19 ± 3, p =0.13; 70°left anterior
oblique, 15 ± 3 versus 18 ± 2, P = 0.047). Thallium
uptake and clearance in the liver, splanchnic region and
spleen were greater after dipyrldamole (p < 0.001). Blood
thallium levels were greater after dipyridamole (p <
0.05) and cleared more slowly (p = 0.07).
Thus. myocardial thallium -201 uptake and clearance
after dipyridamole infusion differ from thallium kinetics
after exercise. This difference is, in part, related to as-
sociated differences in extracardiac and blood kinetics.
Diagnostic criteria for the detection of abnormal thal-
lium-201 clearance must be specific for the type of in-
tervention.
(1 Am Coll Cardiol 1987;10:547-56 )
imaging after dipyridamole-induced hyperemia has become
an accepted alternative to exercise thallium imaging (3-5).
However. computer quantitation of dipyridamole images is
not as widely applied. This is in part because the myocardial
kinetics of thallium after dipyridamole infusion are uncer-
tain. An initial quantitative study (6) used normal criteria
derived from experimental canine models. The kinetics of
thallium after dipyridamole infusion are likely different from
thallium kinetics after exercise because the systemic and
regional hemodynamic effects of these two interventions
differ.
In the present study, we determined the myocardial ki-
netics of thallium-20I after dipyridamole infusion and com-
pared them with those after exercise stress in normal sub-
jects. Inaddition, we assessed extracardiac and blood thallium-
20I kinetics in both groups to explain, in part. observed
differences in myocardial thallium-201 uptake and clear-
ance.
0735-1097/87/$3 .50
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Methods
Study subjects. The study group comprised 21 young
normal volunteers (12 men and 9 women) . These subjects
(aged 20 to 42 years) were nonsmokers and took no med-
ications . None had a history of cardiovascular disease, sys-
temic hypertension or other significant illnesses. All subjects
had normal findings on cardiovascular examination and a
normal electrocardiogram (ECG) . Subjects signed a consent
form approved by the Massachusetts General Hospital Sub-
committee on Human Studies on December 20, 1983. An-
ticipated whole body and renal dosimetry for the thallium-
201 tests was 0.52 rem/2.0 mCi and 4.2 rems/2.0 mCi
respectively, of thallium-20 I.
Study protocol. In seven normal subjects, serial thal-
lium-201 imaging and venous blood sampling were carried
out twice, once after dipyridamole infusion and once after
exercise stress on two separate occasions several weeks
apart . In the other 14 normal subjects, only one thallium
imaging study was possible , either after dipyridamole in-
fusion in 6 or after exercise stress in 8. Subjects were in
the fasting state for both exercise and dipyridamole studies.
Dipyridamole and exercise thallium-20t imaging pro-
tocols. Both the dipyridamole (4,6) and the exercise stress
(7,8) protocols have been described previously. At the be-
ginning of each test , a peripheral intravenous infusion line
was established in an antecubital vein . Heart rate , blood
pressure and a 12 lead ECG were monitored throughout.
For the dipyridamole test, the subject lay supine on a tilt
table . Dipyridamole for intravenous injection was obtained
from Boehringer-Ingelheim under an investigational ex-
emption for a new drug (No. 19,728). Dipyridamole was
infused intravenously at a rate of 0 .14 mg/kg per min for
4 minutes . Although this is the standard dose used clinically,
the pharmacologic response may vary and there may not be
maximal coronary vasodilation in all patients. Intravenous
aminophylline was available for the reversal of severe side
effects such as nausea or dizziness but was not required .
At the end of the 4 minute dipyridamole infusion, the table
was tilted upright. Three minutes later 2.0 mCi thallium-
20 I was injected intravenously and flushed with a bolus
through the indwelling intravenous catheter. The table was
tilted back flat I minute later and imaging was begun.
For the exercise stress test , subjects were exercised on
a treadmill according to the Bruce protocol. All normal
subjects achieved at least 85% of their maximal predicted
heart rate (220 beats/min - age in years). At peak exercise ,
2.0 mCi of thallium-201 was injected and the subject con-
tinued to exercise for I minute longer. Imaging began within
3 minutes of the cessation of exercise. The dose of thallium-
20 I administered was precisely determined with a dose cal-
ibrator (Capintec CRC-12) by measuring the radioactivity
present in the injection syringe before and after administra-
tion.
After either intervention, three sets of 8 minute planar
images were obtained in the anterior, 50° and 70° left an-
terior oblique projections, as previously reported (6,8-10) .
Early images were obtained starting at 2 to 9 minutes (mean
± SD, 5 ± 4 minutes) after injection of thallium-201;
intermediate images at 29 to 54 minutes (41 ± 5) and
delayed images at 95 to 262 minutes (191 ± 48). The early
image corresponds to the usual timing of the initial image
in most clinical protocols. The intermediate image set is not
conventionally acquired , but was added to provide an ad-
ditional time point to more accurately characterize thallium
clearance.
Absolute myocardial and extracardiac thallium up-
take and clearance. All thallium images were analyzed by
two methods. With the first approach, absolute myocardial
and extracardiac thallium uptake (average counts/pixel) was
determined as previously reported (6). A joystick was used
to define 17 regions of interest, 7 cardiac and 10 extracar-
diac . Regions in the anterior view were anterolateral myo-
cardium, inferior myocardium, lung, sternum, liver and
splanchnic region. Regions in the 50° left anterior oblique
view were ventricular septum, posterolateral myocardium,
right ventricle, lung, liver and spleen. Regions in the 70°
left anterior oblique were anterior myocardium, inferior
myocardium, lung, splanchnic region and spleen. No back-
ground subtraction was performed. For each region, thal-
lium clearance (%/h) occurring between imaging times was
calculated as the rate of change in average counts/pixel.
Myocardial thallium clearance was also calculated with
background subtraction by the second method, which is
described next. Early clearance between the early and in-
termediate images and late clearance between the inter-
mediate and delayed images were determined separately.
For calculation of the clearance data, the exact times of the
intermediate and delayed images relative to the early images
were used on an individual patient basis.
Relative myocardial thallium uptake, clearance and
redistribution. With the second approach, a previously
described computer method (7,8-10) with background sub-
traction was used to determine myocardial relative thallium
uptake, clearance and redistribution . In brief, an elliptical
region of interest was placed around the left ventricle and
the region corresponding to the valve planes excluded. Au-
tomatically, the following steps of serial image registration,
background subtraction and determination of thallium-20 I
activity in five segments/view in the early, intermediate and
delayed images were carried out. The count activities within
the myocardium in the three images of each projection were
normalized to the "hottest" 3 X 3 pixel region within the
ellipse of the early image and represent relative thallium
uptake expressed as a percent. Thallium clearance (%/h)
occurring between imaging times was calculated as the rate
of change in segmental counts. In addition, "redistribution"
for each segment was determined by normalizing the hottest
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BP = blood pressure: NS = P > 0.05.
Table I. Hemodynamic Data in 21 Subjects
nificance of the multivariate analyses and are reported in
the tables. The mean myocardial clearance rates were com-
pared with zero clearance using a t test.
The blood time-activity curves of each patient after di-
pyridamole and alter exercise were modeled with multiex-
ponentialdecay functions fit using a nonlinear, least squares
method (RS/l, Bolt Beranek and Newman) (II). The best
fitting model was chosen as the model that simultaneously
had significant coefficients and the greatest F value. The
effect of dipyridamole versus exercise was assessed by com-
paring the group means of the fitted coefficients using a t
test. Comparisons were declared to be statistically signifi-
cant when the two-sided p value was <0.05.
Results
Hemodynamic data (Table 1). Neither heart rate nor
blood pressure at baseline was significantly different before
dipyridamole infusion compared with that before exercise.
At the time of thallium-20I injection, heart rate and blood
pressure were significantly lower after dipyridamole infu-
sion than after peak exercise. The analyses were repeated
including and excluding the seven paired patients and gave
similar results.
Absolute myocardial and extracardiac thallium up-
take and clearance (Tables 2 and 3). Multivariate analysis
of variance demonstrated that the absolute myocardial and
extracardiac thallium uptake at the time of early imaging
after dipyridamole infusion for the 17 regions differed from
that after exercise (p < 0.0001) (Table 2). Early uptake of
thallium-20I was significantly greater after dipyridamole
infusion than after exercise stress in most cardiac regions.
Early uptake was also significantly greater after dipyrida-
mole in the extracardiac regions of the sternum, lung (50°
left anterioroblique projection), liver, splanchnic region and
spleen (Fig. I l. Early thallium-201 uptake after dipyrida-
mole was not significantly different from that after exercise
in the anterolateral myocardial region and lung (anterior and
70° left anterior oblique projections). The analysis was re-
peated using the absolute thallium data of only the seven
Exercise
(0. = 15) P Value
71 ± 13 NS
IX4 ± 9 0.0001
116 ± II NS
165 ± 22 00001
77± II NS
X2 ± 9 o.ot
75 ± 9
69 ± 16
67 ± 12
100 ± 16
115 ± II
102 ± 22
Dipyridamole
(0. = 13)
Heart rate (heats/min)
Baseline
Thallium injection
Systolic HP (nun Hgj
Baseline
Thallium injection
Diastolic HP (rnm Hg)
Baseline
Thallium injection
myocardial 3 x 3 pixel region of the delayed image to
100% and by calculating the difference in relative thallium
uptake between the delayed and early images. We have
previously shown (10) that this second normalization pro-
cess can result in some measurable redistribution in normal
subjects. We have also demonstrated (10) that the inter-
observer and intraobserver variabilities of this quantitative
approach are very small.
To measure blood thallium activity over time. I ml ve-
nous blood samples were collected at 5, 10, 20, 30, 45,
60, 90 and 120minutes after thallium-20l injection by means
of a heparin lock placed in an antecubital vein of the arm
contralateral to that receiving the thallium. The blood sam-
ples were weighed and counted in a well counter (model
8 IOC, Baird Corp.) interfaced with a multichannel analyzer
(series 30, Canberra Industries) with a window of 60 to 200
keV for 2 minutes collecting at least 10,000 counts/sample
(II). The measured blood thallium activity was corrected
for physical decay to the time of collection and expressed
as counts/min-g.
The effect ol differences in the actual dose of thallium-
201 injected (range 1.9 to 2.1 mCi) on regional absolute
thallium-20I uptake and blood thallium levels was elimi-
nated by correcting the values obtained to a 2.0 mCi dose
(measured activity x [2.0/injected dose in mCij).
Statistical analysis. All data were expressed as mean
:±: SD. The seven paired studies were combined with the
unpaired studies resulting in two overall groups (13 dipyr-
idamole and 15 exercise data sets). This approach of ig-
noring the paired aspect of the data may over- or under-
estimate the probability (p) value for the test of mean
differences in the presence of positive or negative correla-
tions within the paired data. A separate analysis of the paired
data demonstrated these correlations to be small and non-
significant.
The means ofthe hemodynamic data for the dipyridamole
group were compared with those of the exercise group with
a t test.
The effects of dipyridamole versus exercise on thallium
kinetics were compared using multivariate analysis of var-
iance (BMDP:P4V, University of California, Los Angeles,
1983). The multivariate p values are reported in the Results
section and are derived from a Hotelling T2 statistic. Four
separate multivariate analyses were performed: I) analyzing
absolute thallium uptake in 17 cardiac and extracardiac re-
gions; 2) analyzing early thallium clearance calculated from
the absolute uptake data; 3) analyzing late thalliumclearance
calculated from the absolute uptake data; and 4) analyzing
simultaneously relative myocardial thallium uptake, clear-
ance and redistribution calculated from the relative myo-
cardial thallium uptake data. When significant group dif-
ferences (dipyridamole versus exercise) were found with the
multivariate analysis, univariate analyses were performed
to determine which variables contributed to the overall sig-
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Table 2. Early Absolute Thallium Uptake (Average Counts/Pixel) in 21 Subjects
Dipyridamole Exercise
Projection Region (n = 13) (n = 15) P Value
Anterior Anterolateral myocardium 554 ± 128 489 ± 78 NS
Inferior myocardium 681 ± 164 541 ± 152 0.027
Lung 182 ± 20 194 ± 46 NS
Sternum 213 ± 26 153 ± 28 0.001
Liver 526 ± 109 227 ± 43 0.001
Splanchnic region 602 ± 174 259 ± 74 0.001
50° Left anterior oblique Septal myocardium 588 ± 159 457 ± 106 0.015
Posterolateral myocardium 618 ± 168 484 ± 114 0.019
Right ventricle 348 ± 103 264 ± 58 0.013
Lung 221 ± 34 176 ± 43 0.005
Liver 402 ± 108 191 ± 56 0.001
Spleen 463 ± 163 224 ± 55 0.001
70° Left anterior oblique Anterior myocardium 542 ± 150 410 ± 98 0.009
Inferior myocardium 624 ± 144 490 ± 133 0.016
Lung 145 ± 23 128 ± 37 NS
Splanchnic region 487 ± 155 222 ± 54 0.001
Spleen 458 ± 129 234 ± 60 0.001
patients with paired dipyridamole and exercise studies and
produced similar results.
Early thallium clearance after dipyridamole infusion dif-
fered from that after exercise for the 17 regions (p = 0.002)
(Table 3). Early clearance was significantly slower after
dipyridamole than after exercise in most myocardial regions
and in the lung (anterior projection) and sternum. In con-
trast, early clearance was significantly faster after dipyrid-
amole than after exercise in the liver and splanchnic region.
Late thallium clearance after dipyridamole infusion dif-
fered from that after exercise for the 17 regions (p = 0.00 I)
(Table 3). Late clearance after dipyridamole compared with
that after exercise did not differ in any of the cardiac regions,
but was significantly faster in the extracardiac regions of
the lung, sternum, liver, splanchnic region and spleen.
Relative myocardial thallium uptake, clearance and
redistribution (Tables 4 to 6). A multivariate analysis of
variance demonstrated that the myocardial thallium kinetics
of relative uptake, clearance and redistribution after dipyr-
idamole differed from that after exercise (p = 0.0006).
Relative thallium uptake in the early image did not differ
after dipyridamole compared with that after exercise. How-
ever, in a model of the effects of group, projection and
segment on early uptake, an interaction between the effects
of projection and segment was significant. Thus, the seg-
mental distribution of relative thallium uptake varied ac-
cording to projection (Table 4).
In contrast, both early and late clearance differed be-
tween the two groups (univariate analysis of variance, p =
0.0002; P = 0.05, respectively). Because of an interaction
Table 3. Early and Late Thallium Clearance Without Background Subtraction (%/h) in 21 Subjects
Dipyridamole Exercise Dipyridamole Exercise
Projection Region (n = 13) (n = 15) P Value (n = 13) (n = 15) P Value
Anterior Anterolateral myocardium 10 ± 14 24 ± 13 0.01 12 ± 4 14 ± 3 NS
Inferior myocardium 14 ± 9 23 ± 11 0.03 14 ± 4 II ± 3 NS
Lung 17 ± II 29 ± 13 0.01 6 ± 3 3 ± 3 0.02
Sternum 7 ± 18 33 ± 15 0.001 7 ± 4 -I ± 3 0.001
Liver 39 ± 12 I ± 24 0.001 13 ± 4 I ± 2 0.001
Splanchnic region 12 ± 20 -15 ± 21 0.002 13 ± 6 -5 ± 5 0.001
50° Left anterior oblique Septal myocardium II ± 10 II ± 20 NS 13 ± 7 12 ± 4 NS
Posterolateral myocardium 13 ± 9 I I ± 20 NS 13 ± 6 II ± 2 NS
Right ventricle 15 ± 8 II ± 20 NS 12 ± 8 8 ± 3 NS
Lung 15 ± 19 24 ± II NS 10 ± 7 2 ± 5 0.001
Liver 34 ± 15 -2 ± 17 0.001 \3 ± 9 1 ± 3 0.001
Spleen 34 ± 84 \0 ± 37 NS 14 ± 9 -3 ± 7 0.00\
70° Left anterior oblique Anterior myocardium 7 ± 7 16 ± 17 0.005 13 ± 7 II ± 3 NS
Inferior myocardium 12 ± 12 17 ± 12 NS 13 ± 6 10 ± 2 NS
Lung -8 ± 39 13 ± 25 NS 5 ± 10 -I ± 8 NS
Splanchnic region 31 ± 14 -13 ± 14 0.001 12 ± 10 o ± 3 0.001
Spleen 6 ± 14 -5 ± 22 NS 13 ± 10 -2 ± 6 0.001
lACC Vol. 10, No.3
September 1987:547-56
RUDDY ET AL.
STRESS THALLlUM-201 KINETICS
551
800
c::===J DP
600 _EX
X
a.
"
400~
...
C
U
lIE
200
ance rates were significantly slower in the dipyridamole
group compared with those of the exercise group in each
projection (Table 5).
Redistribution did not differ either after dipyridamole
compared with that of exercise or among projections, but
it did differ significantly between segments (Table 6).
Blood thallium-20l kinetics (Table 7). The blood thal-
lium-201 time-activity curves, obtained after dipyridamole
infusion and after exercise, were best fitted with a biex-
ponential model:
Figure 1. Comparison of extracardiac early thallium-20l uptake
after dipyridamole (DP) infusion and after exercise (EX). The
regions illustratedare liver (anterior projection), splanchnic region
(anteriorprojection), lung (50° left anterioroblique projection)and
spleen (50° left anterior oblique projection). *p < 0.01 (dipyrid-
amole versus exercise). cnts/px = counts/pixel.
between the effects of group and projection for the variable
of early clearance (p = 0,07), the multivariate analysis was
repeated for each projection separately (Table 5 and Fig.
2). In the anterior projection, both early and late clearance
rates after dipyridamole were significantly different from
those after exercise, In the 50° left anterior oblique projec-
tion, only the early clearance after dipyridamole was sig-
nificantly different from that after exercise. In the 70° left
anterior oblique projection, both early and late clearance
rates of the dipyridamole group differed significantly from
those of the exercise group, A negative early clearance rate
suggesting continued thallium uptake was observed in the
anterior view. The early clearance rates in the 50° 70° left
anterior oblique projections were not significantly different
from zero clearance.
Overall clearance (from the early to the delayed images.
not using data from the intermediate image) was also found
to differ between the two groups using the same multivariate
model of uptake, clearance and redistribution. Because of
a significant interaction between the group and projection
effects for the clearance rate, the multivariate analyses were
carried out separately for each projection. The overall c1ear-
LIVER SPLANCHNIC LUNG SPLEEN
where f(t) = blood thallium activity in counts/ruin-g as a
function of time (minutes) and e is a constant representing
the base of the natural log (2,71828), Mean values of the
constants CI and C2 (early and late counts) and k , and k2
(early and late clearance constants) were calculated for each
group and were used to plot curves representative of the
two groups, The constants, CI and C2, were significantly
greater after dipyridamole infusion than after exercise, in-
dicating greater blood thallium-20 I levels after dipyrida-
mole infusion. There was a trend for the early clearance
constant (k I) to be lower after dipyridamole infusion than
after exercise, However, the later clearance constant (k2)
was significantly greater after dipyridamole (Figs. 3 and 4),
Discussion
Absolute myocardial thallium uptake. Myocardial up-
take of thallium-20 I in normal volunteers was greater after
dipyridamole-induced hyperemia compared with that after
exercise stress, This is consistent with previous reports (\ 2,13)
and reflects several aspects of the differing hemodynamic
effects of dipyridamole and exercise, Myocardial uptake of
thallium-20 I is related to the product of three factors: I)
coronary blood flow relative to cardiac output, 2) extraction
fraction, and 3) dose of isotope, The first factor, the ratio
of coronary blood flow to cardiac output, appears to be larger
during dipyridamole-induced hyperemia than after exercise,
The increase in coronary blood flow with dipyridamole ranges
from 2.4 to 5 times baseline values (\ 4-18), which is greater
than the increase with exercise of 1,7 to 2,5 times baseline
Table 4, Myocardial Distribution of Early Relative Thallium-20I Uptake (C/o) After
Dipyridamole Infusion in 21 Subjects
Segment No.
Projection 2 3 4 5
Anterior 62 ± 9 90 + 6 86 ± 7 89 ± 7 56 ± 12
50° Left anterior oblique 78 ± 10 91 c 4 78 ± 10 73± !O 48 ± 7
70° Left anterior oblique 80 ± (, 93 + 3 82 ± 9 74 ± II 64± 13
Segment No. = number of myocardial scgments from quantitative analysis program, numbered clockwise
with segment I being anterobasal in the anterior projection, superior posterolateral in the 50° left anterior
oblique projection projection and inferobasal in the 70° left anterior oblique projection.
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Table 5. Early, Late and Overall Myocardial Thallium Clearance (Background Subtracted)
in 21 Subjects*
Time Dipyridamole Exercise
Projection Interval (n = 13) (n = 15) P Value
Anterior Early -II ± 17 24 ± 5 0.0005
Late 15 ± 4 20 ± 2 0.025
Overall 10 ± 6 20 ± 2 0.0001
50° Left anterior oblique Early -7 ± 11* 15 ± 8 0.004
Late \5 ± 4 19 ± 3 NS
Overall 10 ± 3 17 ± 2 0.00\
70° Left anterior oblique Early 3 ± 9* 22 ± 6 0.004
Late 15 ± 3 18 ± 2 0.047
Overall 12 ± 3 \8 ± 2 0.003
*Clearance expressed as the average of five segments/projection and in %/h: *not different from 0 clearance.
Table 6. Segmental Values of Redistribution After
Dipyridamole Infusion (Projections Combined)
(15,19,20). Conversely, dipyridamole causes a smaller in-
crease in cardiac output, reported to be 1.3 times the baseline
value (17), compared with the three- to fivefold increase
reported with exercise (2\). Thus, the ratio of coronary
blood flow to cardiac output after dipyridamole would be
greater than after exercise and would favor greater myo-
cardial thallium-201 uptake after dipyridamole.
The impact of the second factor affecting myocardial
thallium-20J uptake, extraction fraction, is uncertain (22-25).
One study (23) suggested that the extraction fraction of
thallium-20 I decreases to a greater degree with hyperemia
due to dipyridamole compared with hyperemia due to in-
creased cardiac work. In another study (25), the decrease
in extraction fraction at high flows was similar during di-
pyridamole-induced hyperemia and after exercise. Thus, the
greater coronary flows after dipyridamole compared with
exercise may be associated with a lower extraction fraction
of thallium-20l, which would offset the greater thallium-
20 I delivery to the myocardium.
The third factor affecting myocardial uptake of thallium-
20 I is isotope dose. As discussed later, blood levels of
thallium are higher after dipyridamole. In addition, the hy-
peremia after dipyridamole may persist longer than it does
after exercise. Therefore, the heart is exposed to more thal-
lium after dipyridamole, and this may contribute to the
greater myocardial uptake of thallium.
Absolute extracardiac thallium uptake and clearance.
Whole body thallium-20l imaging has been used to visualize
regional cardiac output in humans and experimental animals
30
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(26). The differences in early regional thallium-201 uptake
after dipyridamole compared with exercise are most likely
related to regional blood flow differences. With exercise in
humans, the increase in cardiac output is proportioned mainly
to the exercising muscles (27). Several studies (28,29) have
shown a reduction in splanchnic and renal blood flow with
exercise that is roughly proportional to the severity of ex-
ercise. In contrast, regional blood flow after dipyridamole
infusion more closely resembles that of the rest state. Ac-
cordingly, thallium-20 I uptake in the regions of the splanch-
nic circulation, liver and spleen was less after exercise than
after dipyridamole. Thallium-201 uptake in thigh muscle
has been reported (13) to be increased much more than
myocardial uptake ofthallium-201 with bicycle exercise and
to be decreased after dipyridamole. Lung uptake of thallium-
20 I has also been found to be greater after dipyridamole
than after exercise (12,13), as we observed in the 50° left
anterior oblique projection, and may be related to the longer
Figure 2. Comparisonof myocardial early thallium-20I clearance
(with background subtraction) after dipyridamole (DP) infusion
and after exercise (EX) in the anterior, 500 left anterior oblique
(LAO) and 700 left anterior oblique projections. *p < 0.01 (di-
pyridamole versus exercise).
5
3 ± 4
4
2 ± 3
3
2 ± 4
Segment No. *
2
6 ± 49 ± 4Redistrihution
*p = 0.0001 for the comparison between mean segmental values;
Segment No. as in Table 4.
-20
ANTERIOR 50 LAO 70 LAO
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Table 7. Mean Values of the Coefficients Determined From the Individual Blood Time-Activity
Curves (Seven Paired Studies)
Constant* Dipyridamole Exercise p Value
CI (counts/min-g) 132,802 :+: 33,074 <)2,248 :+: 31,955 0.046
C2 (counts/min-g) 15,802 :+: 5,146 6,736 :+: 2,334 0.00189
k, (min' I) 0.166 :+: 0.030 o 198 :+: 0.016 0.07
k2 (min I) 0.0051 :+: 0.0021 0.0020 :+: 0.0008 0.005
*Constants correspond 10 HI) = c.e 'i + C2e '2'.
M/NUTES
,-._----- --,--.- ._--
Figure 3. Comparison of blood thallium-20l kinetics after di-
pyridamole infusion and after exercise. The blood clearance data
of each patient was fitted with a biexponential model using a
nonlinear least squares method. The curves were drawn using the
group mean values of the estimated coefficients.
early thallium-201 clearance was much slower after dipyr-
idamole compared with exercise and not different from zero
clearance. Late clearance determined from the intermediate
and delayed images was mildly decreased after dipyridamole
compared with exercise. These differences in early and late
thallium-201 myocardial clearance after dipyridamole in-
fusion compared with exercise stress may be related to two
factors: I) liver and splanchnic thallium-201 uptake and
early clearance are much greater after dipyridamole com-
pared with exercise and may result in a continued influx of
thallium-20 I into the bloodstream and into myocardium dur-
ing the time interval between the early and intermediate
images. Conversely, with exercise, the greatest extracardiac
uptake of thallium-201 occurs in exercising skeletal muscle
and clears very slowly (13). Thus, the extracardiac reservoir
for thallium-20 I in the liver and splanchnic circulation after
dipyridamole acts more like an "internal infusion pump",
whereas the extracardiac thallium-20 I reservoir in skeletal
muscle after exercise acts more like a "sink." 2) The higher
blood levels after dipyridamole would decrease the concen-
tration gradient between myocardium and decreased myo-
cardial clearance.
We considered the possibility that the quantitative dif-
ferences in early clearance between the two groups may be
a result oj" background subtraction. With greater back-
ground activity in the early images compared with the in-
termediate images, excessive background subtraction may
result in much greater subtraction of background from the
myocardial activity in the early image than from the myo-
cardial activity in the intermediate image and artifactually
create the observed pattern of zero or negative clearance
between the early and intermediate images observed after
dipyridamole. However, this effect of background subtrac-
tion is unlikely for two reasons. First, background activity
primarily comprised lung activity for the anterolateral, pos-
terolateral, septal and anterior regions and splanchnic ac-
tivity for the inferior and apical regions. Both the uptake
and the early clearance of these background regions differed
between the two groups. If excessive background subtrac-
tion was having a major effect, the lung thallium-20 I kinetic
pattern of similar or mildly increased uptake after dipyr-
idamole combined with greater or similar clearance after
exercise would favor decreased clearance after exercise or
similar clearance in both groups for the myocardial segments
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pulmonary transit time with the lower heart rates during
dipyridamole hyperemia, which results in less time for thal-
lium-201 uptake (30), The greater thallium-201 blood levels
after dipyridamole infusion would also have resulted in higher
tissue levels of thallium-201 in all regions.
The faster clearances of thallium-201 from the liver.
splanchnic region and spleen after dipyridamole compared
with exercise may be related to much greater tissue/blood
thallium-201 gradients because the early thallium-201 up-
take values of these regions were much greater after dipyr-
idamole infusion and offset the higher blood thallium-201
levels after dipyridamole infusion. Conversely, the slower
clearance from lung and sternal regions (anterior projection)
after dipyridamole may reflect lower tissue/blood gradients
after dipyridamole because the early thallium-201 uptake
data of these regions after dipyridamole were much more
similar to those after exercise, allowing the effect of higher
blood thallium-201 levels after dipyridamole to predomi-
nate.
Myocardial thallium clearance with background sub-
traction. The pattern of myocardial thallium clearance after
dipyridamole was always slower compared with that after
exercise. Between the early and intermediate images in the
anterior projection, thallium-20l actually filled in after di-
pyridamole. In the 50° and 70° left anterior oblique views,
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Figure 4. Comparison of early, intermediate and delayed
thallium-201 images obtained after dipyridamole infusion (top)
and after exercise (bottom). These images were acquired in
the same patient in the 50° left anterior oblique projection at
similar times (approximately 5. 45 and 180 minutes) after
injection of similar doses of thallium-201 . Myocardialuptake
of thallium-201 at each imaging time is greater after dipyr-
idamole compared with exercise. The myocardial clearance
of thall ium-201 is much slower after dipyridamole than after
exercise .
adjacent to lung. Similarly, excessive subtraction of back-
ground determined from the splanchnic region. with greater
early uptake and more rapid early clearance after dipyrid-
amole, would tend to produce slower or negative early myo-
cardial clearance in the inferior and apical segments after
dipyridamole. However. there was no significant segmental
effect on early clearance in either group or any interaction
with the effect of projection, Segmental early clearance rates
were similar in a given projection in either group, Second,
the difference in the myocardial clearance of thallium-20I
between the early and intermediate images after dipyrida-
mole infusion compared with that after exercise was so
substantial that it could be noted visually in some patients
(Fig. 4),
The determination of myocardial thallium-Zt)l uptake with
planar imaging is compli cated by the need f or background
subtraction because the recorded activity from a region over
the heart comprises activity arising from the heart and from
overlying lung and intercostal muscle. Background sub-
traction methods that utilize areas of lung adjacent to the
myocardium appear to "oversubtracr" background (31) re-
sulting in underestimations of true myocardial activity. The
recent development of rotational tomographic imaging of-
fers one potential solution to this problem of overlying back-
ground activity and may make possible more accurate de-
terminations of myocardialthallium-201 uptake and clearance.
Such measurements were not available in this study.
The zero or negati ve early clearance rate (or continued
uptake of thallium-201) after dipyridamole may be an ad-
vantage for the detecti on of coronary stenoses . The defi-
nition of relative perfusion defects due to coronary artery
stenoses should improve if thallium-201 uptake continues
to occur during persistent dipyridamole-induced flow dis-
parity. Because a negative clearance rate significantly dif-
ferent from zero clearance was observed in only the anterior
projection. it is likely that it only occurs in the first 10 to
20 minutes after thallium injection. This is consistent with
peak myocardial thallium-201 uptake occurring soon after
the acquisition of the early anterior image. The coronary
vasodilator effect of intravenous dipyridamole has a half-
life of 33 minutes in humans (17). Thus. imaging at ap-
proximately 10 minutes after thallium-201 injection should
provide images of maximal thallium-201 uptake with pres-
ervation of relative thaJlium-20 I perfusion differences.
Therefore. since this study, we have delayed the time of
our initial anterior acquisition to 10 minutes instead of the
2 minutes used in this study and with exercise. In addition.
we do not routinely acquire an intermediate image.
Although the timing of peak myocardial thallium-201
uptake appears to be related primarily to extracardiac clear-
ance, the presence of coronary artery disease may delay the
timing of peak myocardial activity. as has been reported in
canine studies ( I I). If the peak myocardial uptake occurs
after the dipyridamole hyperemic effect has resolved, either
because of a prolonged time to peak myocardial uptake or
because of administration of aminophylline. the continued
thallium-201 uptake may decrease previous differences in
relative thallium-20t uptake. The zero early clearance of
thallium-20I observed in the 50° and 70° left anterioroblique
projections suggests that a delay in obtaining the initial set
of images after dipyridamole may not adversely affect sen-
sitivity for detection of transient thallium defects. as has
been reported for exercise thallium imaging (32).
Blood thallium kinetics. The greater thallium-20I blood
levels after dipyridamole suggest that the early volume of
distribution for thallium-20I may be smaller after dipyrid-
amole infusion and may be related to differences in extra-
cardiac early uptake of thallium-20l. Bull et al. (1 3) cal-
culated that skeletal muscle takes up about two-thirds of the
thallium-20I dose injected at peak exercise. In contrast.
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after dipyridamole infusion, the extracardiac uptake of thal-
lium-20l occurs primarily by the smaller tissue mass of the
liver, spleen and splanchnic circulation. The continued el-
evation and slower clearance of the blood thallium-20 I lev-
els after dipyridamole can be attributed to the rapid early
clearance of thallium-20l from the splanchnic and liver
reservoirs, which contrasts with the "trapping" of thallium-
201 by exercising skeletal muscle.
Potential limitations of this study. Although the results
and conclusions of this study are based on a relatively small
number of subjects, the differences observed were statisti-
cally significant. Furthermore, the results are not necessarily
applicable and transferable to patients with coronary artery
disease because this study was performed in normal vol-
unteers. Confirmation of the observed differences between
dipyridamole and exercise thallium kinetics would be de-
sirable in patients with coronary artery disease.
Clinical implications. Diagnostic criteria for the detec-
tion of coronary artery disease using quantitative analysis
utilize variables based on the relative distribution of early
thallium-20l uptake and subsequent clearance. Because the
normal pattern of thallium-20 I clearance after dipyridamole-
induced hyperemia differs from that after exercise stress,
quantitative normal limits specific for dipyridamole stress
must be used (Tables 5 to 7). Because the normal clearance
rate is slower after dipyridamole than after exercise, apply-
ing diagnostic criteria developed from exercise data to di-
pyridamole images would most likely increase the rate of
false positive results and decrease specificity. The zero or
negative early clearance of thallium after dipyridamole sug-
gests that the initial thallium images should be acquired later
after dipyridamole than after exercise. Further studies in
patients with coronary artery disease using early and inter-
mediate imaging may determine the optimal time of initial
imaging for maximal diagnostic accuracy.
We acknowledge the technical assistance of Maureen McCarthy. Gerard
Cotler and William Shea.
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